4//SEC Filing
GOODMAN COREY S 4
Accession 0001567619-21-012858
CIK 0001783032other
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 5:27 PM ET
Size
16.0 KB
Accession
0001567619-21-012858
Insider Transaction Report
Form 4
Adelman Robert J
10% Owner
Transactions
- Purchase
Common Stock
2021-06-29$16.00/sh+625,000$10,000,000→ 2,608,167 total - Conversion
Series B Preferred Stock
2021-06-29−8,380,034→ 0 total→ Common Stock (1,983,167 underlying) - Conversion
Common Stock
2021-06-29+1,983,167→ 1,983,167 total
VENBIO GLOBAL STRATEGIC GP III, L.P.
10% Owner
Transactions
- Purchase
Common Stock
2021-06-29$16.00/sh+625,000$10,000,000→ 2,608,167 total - Conversion
Common Stock
2021-06-29+1,983,167→ 1,983,167 total - Conversion
Series B Preferred Stock
2021-06-29−8,380,034→ 0 total→ Common Stock (1,983,167 underlying)
Royston Aaron
10% Owner
Transactions
- Conversion
Series B Preferred Stock
2021-06-29−8,380,034→ 0 total→ Common Stock (1,983,167 underlying) - Conversion
Common Stock
2021-06-29+1,983,167→ 1,983,167 total - Purchase
Common Stock
2021-06-29$16.00/sh+625,000$10,000,000→ 2,608,167 total
GOODMAN COREY S
10% Owner
Transactions
- Conversion
Series B Preferred Stock
2021-06-29−8,380,034→ 0 total→ Common Stock (1,983,167 underlying) - Purchase
Common Stock
2021-06-29$16.00/sh+625,000$10,000,000→ 2,608,167 total - Conversion
Common Stock
2021-06-29+1,983,167→ 1,983,167 total
Transactions
- Conversion
Common Stock
2021-06-29+1,983,167→ 1,983,167 total - Conversion
Series B Preferred Stock
2021-06-29−8,380,034→ 0 total→ Common Stock (1,983,167 underlying) - Purchase
Common Stock
2021-06-29$16.00/sh+625,000$10,000,000→ 2,608,167 total
Footnotes (2)
- [F1]Each share of Series B Preferred Stock automatically converted into approximately 0.236654 shares of the Issuer's common stock immediately prior to the completion of the Issuer's initial public offering. The Series B Preferred Stock had no expiration date.
- [F2]The shares are held by venBio Global Strategic Fund III, L.P. venBio Global Strategic GP III, L.P. is the sole general partner of venBio Global Strategic Fund III, L.P. and venBio Global Strategic GP III, Ltd. is the sole general partner of venBio Global Strategic GP III, L.P. Each of Corey Goodman, Robert Adelman and Aaron Royston is a director of venBio Global Strategic GP III, Ltd. Each of venBio Global Strategic GP III, L.P., venBio Global Strategic GP III, Ltd, Dr. Goodman, Dr. Adelman and Dr. Royston disclaims beneficial ownership of such securities, except to the extent of its/his indirect pecuniary interest therein.
Documents
Issuer
Elevation Oncology, Inc.
CIK 0001783032
Entity typeother
Related Parties
1- filerCIK 0001278411
Filing Metadata
- Form type
- 4
- Filed
- Jun 30, 8:00 PM ET
- Accepted
- Jul 1, 5:27 PM ET
- Size
- 16.0 KB